Label: DIPHENHYDRAMINE HYDROCHLORIDE capsule

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated January 20, 2020

If you are a consumer or patient please visit this version.

  • PURPOSE

    Antihistamine

  • USES

    Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies


    runny nose and sneezing

    itching of the nose or throat

    itchy, watery eyes.

  • WARNINGS

    Ask a doctor before use if you have


    a breathing problem such as emphysema or chronic bronchitis

    glaucoma

    difficulty in urination due to enlargement of the prostate gland

    Do not use with any other product containing diphenhydramine, including products used topically.

    Ask a doctor or pharmacist before use if you are


    taking tranquilizers or sedatives

    taking other products containing diphenhydramine

    When using this product


    Do not exceed recommended dosage

    excitability may occur, especially in children

    marked drowsiness may occur

    alcohol, sedatives, and tranquilizers may increase drowsiness

    avoid alcoholic drinks

    use caution when driving a motor vehicle or operating machinery

    If pregnant or breastfeeding ask a health professional before use.

  • KEEP OUT OF THE REACH OF CHILDREN.

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • DIRECTIONS

    DIRECTIONS


    Adults and Children 12 years and over: 25 to 50 mg (1 to 2 capsules) every 4 to 6 hours, not to exceed 12 capsules in 24 hours.

    Children 12 years and under: Consult a Doctor

  • STORAGE AND HANDLING

    Keep tightly closed. Store at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature].

    Manufactured for Sandoz Inc.

    Princeton, NJ 08540

    Manufactured by Epic Pharma, LLC

    Laurelton, NY 11413

    L1812

    Rev. 11/08

  • INACTIVE INGREDIENTS

    Colloidal Silicon Dioxide, Corn Starch, D&C Red #28, FD&C Blue #1, FD&C Red #40, Gelatin, Anhydrous Lactose, Magnesium Stearate, Silicon Dioxide and Sodium Lauryl Sulfate.

  • DOSAGE & ADMINISTRATION

    Adults and Children 12 years and over: 25 to 50 mg (1 to 2 capsules) every 4 to 6 hours, not to exceed 12 capsules in 24 hours.

    Children 12 years and under: Consult a Doctor

  • PURPOSE

    Antihistamine

  • KEEP OUT OF THE REACH OF CHILDREN.

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • ACTIVE INGREDIENT SECTION

    Diphenhydramine Hydrochloride 25 mg

    Diphenhydramine Hydrochloride 50 mg

  • PACKAGE LABEL - PRINCIPAL DISPLAY PANEL

    67296-0876

  • INGREDIENTS AND APPEARANCE
    DIPHENHYDRAMINE HYDROCHLORIDE 
    diphenhydramine hydrochloride capsule
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:67296-0876(NDC:0185-0648)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DIPHENHYDRAMINE HYDROCHLORIDE (UNII: TC2D6JAD40) (DIPHENHYDRAMINE - UNII:8GTS82S83M) DIPHENHYDRAMINE HYDROCHLORIDE25 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    D&C RED NO. 28 (UNII: 767IP0Y5NH)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    GELATIN (UNII: 2G86QN327L)  
    Product Characteristics
    Colorpink (pink top/clear body) Scoreno score
    ShapeCAPSULESize14mm
    FlavorImprint Code E648
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:67296-0876-124 in 1 BOTTLE; Type 0: Not a Combination Product05/01/2000
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34105/01/2000
    Labeler - RedPharm Drug, Inc. (828374897)
    Establishment
    NameAddressID/FEIBusiness Operations
    RedPharm Drug, Inc.828374897repack(67296-0876) , relabel(67296-0876)